‘A key pillar of the future’: Givaudan tips growth for ingredients developed with green biotech
Mathias Fleury, Givaudan’s global category manager of biotech actives, told CosmeticsDesign-Asia that leveraging on green biotechnology would allow companies to find solutions to consumers’ desire for products that are natural, sustainable and high-performing.
“Green Biotech truly is a key pillar of the future. Consumers are looking for more naturality while protecting nature – a difficult challenge, made possible by biotech – along with a high level of innovation,” said Fleury.
Most recently, the Swiss company collaborated with South Korean biotech company BIO-FD&C to tackle two frustrating beauty concerns by leveraging on green biotechnology.
It recently unveiled two actives, K-phyto [SC] Camellia and K-phyto [PP] GHK, which were developed to address dry scalp and oily skin respectively.
“This exclusive partnership with Bio FD&C leverages the untapped power of plants through stem cell cultures and unique phytopeptides. It allows our experts to offer innovative natural and reliable solutions for hair and skin care issues such as dry scalp and oily skin, while protecting our planet,” said Fleury.
Plant power
K-phyto [SC] Camellia is an ingredient obtained from camellia phytoplacenta cells culture.
According to the company, the active can increase the scalp moisture content by 13.8%. This reinforces the epidermal cohesion of the scalp keratinocytes and reduces dry flakes and dandruff down by 33.6%.
It also was observed soothe the scalp by being able to reduce erythema down 6.6%.
According to Givaudan, having botanical claims with popular ingredients such as camellia, more commonly known as Tsubaki in the region, can drive hair care product launches by 70% in APAC.
The second ingredient, K-phyto [PP] GHK, is a molecule that combines botanicals and peptides to act on the mechanisms of sebum production.
Clinical studies have shown facial sebum production reduction by 35.5% in two weeks and 67.5% in one month.
“Oily skin is a major claim requested by the market, specifically in APAC. Clinical results with the phytopeptide we've chosen to bring to market are outstanding and we definitely believe this could be a game changer,” said Fluery.
The Swiss firm believes that the two actives showed a lot of promise for the global market.
“Our partner was already doing a very good job in its local market, but we want to leverage our access to different places over the world to highlight its expertise and know-how. This collaboration is a real opportunity to bring innovative ingredients to consumers globally, and that's why we'll offer these products to our partners all over the world,” said Fleury.
Additionally, these ingredients are aligned with the ideals of clean beauty, one of the most talked-about trends in the beauty market right now.
“The two technologies that we've identified in Bio FD&C portfolio are a perfect answer to this need of clean beauty combined with performance,” said Fluery.
